Welcome

Investor Contact

Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Investor Home

Investor Presentation

BioLife Solutions Investor Presentation January 2024

Recent Events

BioLife Solutions, Inc. Q2 2024 Earnings Conference Call and Business Update

Thursday, August 8, 2024

1:30pm - 2:30pm PDT

Add to Calendar

Set Email Reminder

Latest News

Get News Alerts by Email

Jul 25, 2024

BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced...

May 29, 2024

BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver

New container developed for the needs of cell and gene therapy (CGT) primary packaging to replace cryopreservation bags with a fracture resistant, rigid construction built for both manual use and...

View All News and Press Releases